What is the current stock price of AVAX Technologies, Inc. (AVXT)?

As of the latest market data, AVAX Technologies, Inc. (AVXT) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does AVAX Technologies, Inc. (AVXT) pay a dividend?

Based on current data, AVAX Technologies, Inc. does not have a confirmed active dividend policy.

What is the market cap of AVAX Technologies, Inc.?

The current market capitalization of AVAX Technologies, Inc. (AVXT) is approximately unavailable.

AVXT

AVAX Technologies, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

1997-05-15

Beta

-55.48

Websitewww.avax-tech.com↗